Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4A | P47712 | 1/20 | 0.65 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.61 |
| ▸ | CNR1 | P21554 | 1/20 | 0.61 |
| ▸ | CETP | P11597 | 3/20 | 0.60 |
| ▸ | THRB | P10828 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | CNR2 | P34972 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | FAAH | O00519 | 3/20 | 0.56 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.55 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15295511 | 1.00 | PLA2G4A (0.65) | PLA2G4ADEGS1CNR1CETPTHRB | |
| SCHEMBL22911038 | 1.00 | PLA2G4A (0.65) | PLA2G4ADEGS1CNR1CETPTHRB | |
| SCHEMBL22910834 | 1.00 | PLA2G4A (0.65) | PLA2G4ADEGS1CNR1CETPTHRB | |
| SCHEMBL22910816 | 1.00 | PLA2G4A (0.65) | PLA2G4ADEGS1CNR1CETPTHRB | |
| SCHEMBL22910819 | 1.00 | PLA2G4A (0.65) | PLA2G4ADEGS1CNR1CETPTHRB | |
| SCHEMBL23016760 | 1.00 | PLA2G4A (0.65) | PLA2G4ADEGS1CNR1CETPTHRB | |
| SCHEMBL22911231 | 1.00 | PLA2G4A (0.65) | PLA2G4ADEGS1CNR1CETPTHRB | |
| SCHEMBL22910798 | 1.00 | PLA2G4A (0.65) | PLA2G4ADEGS1CNR1CETPTHRB | |
| SCHEMBL22910840 | 1.00 | PLA2G4A (0.65) | PLA2G4ADEGS1CNR1CETPTHRB | |
| SCHEMBL21428472 | 0.97 | PLA2G4A (0.62) | PLA2G4ADEGS1CNR1CETPTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210015767-A1 | ARTIFICIALLY SYNTHESIZED SPHINGOSINE DERIVATIVE LIPOID MONOMER AND USE OF SAME FOR DELIVERING NUCLEIC ACID | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2021-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210015767-A1 | ARTIFICIALLY SYNTHESIZED SPHINGOSINE DERIVATIVE LIPOID MONOMER AND USE OF SAME FOR DELIVERING NUCLEIC ACID | SPHK2, SPHK1, S1PR2 | PLA2G4A 65/4885DEGS1 41/4885CNR1 378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.